Open AccessActive surveillance for low-risk prostate cancer – in pursuit of a standardized protocol
Author(s) -
Roman Sosnowski,
Hubert Kamecki,
Siamak Daneshmand,
J Rudziñski,
Marc A. Bjurlin,
Francesco Giganti,
Monique J. Roobol,
Laurence Klotz
Publication year - 2020
Publication title -
central european journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.403
H-Index - 20
eISSN - 2080-4873
pISSN - 2080-4806
DOI - 10.5173/ceju.2020.0167
Subject(s) - protocol (science) , medicine , prostate cancer , observational study , clinical practice , cancer , medical physics , intensive care medicine , gynecology , alternative medicine , family medicine , pathology
Active surveillance (AS) is a management option recommended by most guidelines for low risk clinically-localized prostate cancer (LR-CLPC). Data shows that AS is being increasingly adopted into clinical practice worldwide. Our aim was to review the up-to date guidelines and observational studies in regards to AS in LR-CLRPC to gain insight into principles of contemporary clinical practice.